Overview

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This is an open-label study evaluating multiple doses of GS-7340 versus Tenofovir disoproxil fumarate (TDF).
Phase:
Phase 1
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Tenofovir